No abstract available.
Skin*

No abstract available.
Child* ; Humans ; Rheumatic Fever* ; Rheumatic Heart Disease*

No abstract available.
Osteochondroma*

PURPOSE: Transurethral prostatectomy(TURP) or open prostatectomy were considered as standard treatments for benign prostatic hyperplasia(BPH), but these treatments showed high morbidity and mortality. We searched urodynamic predictive factors for successful surgical outcome to select patients who would benefit from prostatectomy pre-operatively. MATERIALS AND METHODS: Retrospectively, we reviewed preoperative urodynamic findings of 114 patients with BPH undergoing TURP(104cases) or open prostatectomy(10cases). RESULTS: In the follow-up period of 1 month to 19 months, a strict successes were achieved in 83 patients(73%). On analysis of the success rate, 4 favorable urodynamic factors and 8 unfavorable urodynamic factors were noted. 4 favorable factors were as follows; maximal flow rate<10ml/sec, compressive flow pattern, prostatic urethral length >6cm and presence of peak elevation on prostatic urethra pressure. 8 unfavorable factors were as follow; intermittent or normal flow pattern, prostatic urethral length<4cm, maximal detrusor pressure<10cmH2O, maximal bladder capacity<250ml, maximal urethral pressure >100cmH2O, prostatic pressure area <70cm cmH2O, non-obstructive pattern on Abrams-Griffiths nomogram and detrusor pressure at maximal flow rate <50cmH2O. CONCLUSIONS: Patients with more than 1 unfavorable urodynamic factor should be investigated carefully before surgery and be treated with other non-invasive treatment for BPH. The presence of 2 favorable urodynamic factors without unfavorable factor will usually predict the best surgical outcome.
Follow-Up Studies ; Humans ; Mortality ; Nomograms ; Prostatectomy ; Prostatic Hyperplasia* ; Retrospective Studies ; Treatment Outcome* ; Urethra ; Urinary Bladder ; Urodynamics*

Acoustic stimulation test(AST), is currently being used as an alternative tool of nonstress test (NST). However, there are no standard guideline for analysis of AST. Computerized numerical analysis of AST would be helpful for development of diagnostic criteria of AST. Fifty-one normal pre-term pregnancies entered to this study after conventional 20-minutes NST and 10-minutes AST. Acoustic stimulations were performed using Fetal Acoustic Stimulator (Model 146, Corometrics, US). We analyzed the FHR response after acoustic stimulation using our on-line computerized FHR analysis system, HYFM-I & II software. The changes of loss of signal, baseline FHR, variability, number of fetal movements, and number of FHR accelerations were analyzed numerically. The loss of signal was increased about 2 fold(122.61%). The baseline FHR was increased from 144.57bpm to 156.81bpm(8.5%) after acoustic stimulation. Number of fetal movements was increased about 2 fold(from 2.1 to 4.12/10 minutes). FHR variability was also increased from 17.81 bpm to 26.37 bpm. After AST, number of FHR accelaration was increased 55.47%(10sec 10bpm) and 68.42%(15sec 15bpm), respectively. In this study, we acrumulated elemental FHR data using computerized system after AST. These data would be helpful in the accurate analysis of AST and also enable us to develop the objective interpretation system for AST.
Acceleration ; Acoustic Stimulation* ; Acoustics* ; Female ; Fetal Heart* ; Fetal Movement ; Heart Rate, Fetal* ; Pregnancy ; Pregnancy*

Urine specimens from 60 consecutive patients with hematuria were examined with an autoanalyzer (Coulter counter model S-PLUS JR) to obtain the urinary red cell size distribution curve an mean cellular volume (MCV). Glomerular and nonglomerular red blood cells showed large differences with respect to size distribution, with the peak for glomerular cells at a smaller volume (MCV value 68.40+/-4.32fl) in comparison with the normal size distribution of nonglomerular cells (MCV value 96.78+/-5.76fl). A definite diagnosis was made which correlated with urinary red cell mean cellular volume in of 39 patients (94%) with nonglomerular hematuria and in 20 of 21 patients (95%) with glomerular hematuria. Identification of glomerular (MCV values below 80 fl) and nonglomerular hematuria (MCV values above 80 fl) can be of practical use in the clinical managements of patients. We think that this simple diagnostic work up should be adopted in the routine screening test for patient with hematuria.
Cell Size ; Diagnosis ; Erythrocytes* ; Hematuria* ; Humans ; Mass Screening

Recently we experienced 20 cases of benign prostatic hypertrophy applied with spiral urethral prosthesis. Seventeen patients showed satisfactory voiding just after the procedure and the average flow rate was 12 ml/sec. The remaining 3 patients got well within 2 days. 1 to 14 months of follow-up was done with urine flow rate, voiding symptoms, urine studies, the presence of hematuria and complications, etc. Most of all patients showed urgency initially. but it was disappeared several days. Twelve cases of hematuria and 1 case of stone formation were noted. We believe that implantation of spiral urethral prosthesis (Prostakath TM) is an acceptable procedure for the treatment of benign prostatic hypertrophy in high risk patients to a prostatic operation.
Follow-Up Studies ; Hematuria ; Humans ; Prostatic Hyperplasia* ; Prostheses and Implants

We report a rare case of bilateral transitional cell carcinoma of the ureter associated with acute renal failure. After unilateral percutaneous nephrostomy, right nephroureterectomy was performed without complete resection of the ureteral tumor. Following two cycles of chemotherapy. left upper ureteral obstruction was considerably decompressed with normal renal function.
Acute Kidney Injury* ; Carcinoma, Transitional Cell ; Drug Therapy ; Nephrostomy, Percutaneous ; Ureter* ; Ureteral Obstruction

No abstract available.
Humans ; Rhinitis* ; Skin Tests* ; Skin*

PURPOSE: Neuroendocrine (NE) cells of the prostate are considered to be involved in the pathogenesis of benign prostate hyperplasia (BPH). By a comparative analysis of NE cell density in BPH tissue of men who were either exposed to or not exposed to 5alpha-reductase inhibitor, we investigated the relationship between NE cells and BPH, and the effect of androgen deprivation on NE cells. MATERIALS AND METHODS: Prostate tissue specimens, obtained from 30 men by transurethral resection of the prostate or radical cystoprostatectomy, were used. Of the 30 patients, 10 had a prostate smaller than 25 ml (normal control), the other 20 had a prostate larger than 40ml, 10 of who had taken 5alpha-reductase inhibitor (finasteride) for 3 months before surgery (androgen blockade group), and 10 who had not (BPH group). The distribution of NE cells in the prostate was examined using the anti-chromogranin A (CgA) antibody, and the density of the CgA-positive cells was compared by an optical dissector method. Immunoblotting was performed using the neuron specific enolase (NSE) antibody. A Mann-Whitney U test was used in a statistical analysis. RESULTS: Most of the CgA-positive NE cells were localized between the acinar epithelial cells. The mean numbers of CgA-positive NE cells per acinus in the normal controls and the BPH groups were 1.67+/-0.78 and 4.45+/-2.54, respectively, and the difference was statistically significant (p<0.05). However, the mean number of CgA-positive NE cells in the androgen blockade group, was 4.93+/-2.17, which was similar to the BPH group. In a NSE immunoblotting study, a distinct band was observed in the BPH and androgen blockade groups, but the density of the band was higher in the androgen blockade group. CONCLUSIONS: Our results suggest that NE cells may be involved in the hyperplastic process of BPH. Inhibition of dihydrotestosterone, caused by the oral administration of the 5alpha-reductase inhibitor, failed to induce any significant change in the NE cells, probably due to the incomplete androgen blockade.
Administration, Oral ; Cell Count ; Dihydrotestosterone* ; Epithelial Cells ; Humans ; Hyperplasia ; Immunoblotting ; Male ; Neuroendocrine Cells* ; Phosphopyruvate Hydratase ; Prostate ; Prostatic Hyperplasia*